The Trace Amine 1 receptor knockout mouse: An animal model with relevance to schizophrenia

Genes, Brain and Behavior

Volumn 6, Issue 7, 2007, Pages 628-639

  Wolinsky, T D ^a   Swanson, C J ^a   Smith, K E ^a   Zhong, H ^a   Borowsky, B ^a,c   Seeman, P ^b   Branchek, T ^a   Gerald, C P ^a  

^a LUNDBECK RESEARCH USA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c SANOFI   (France)

Author keywords

Amphetamine; D2 receptor; Dopamine; Locomotor activity; Mouse; Prepulse inhibition; Trace amine

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; NORADRENALIN; RECEPTOR; TRACE AMINE 1 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BEHAVIOR; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINE RELEASE; EMBRYO; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REGULATORY MECHANISM; SCHIZOPHRENIA; WILD TYPE;

AMPHETAMINE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; GENE TARGETING; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; MOTOR ACTIVITY; PHENOTYPE; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION; STRESS, PSYCHOLOGICAL;

ANIMALIA; MUS; PRIMATES; RATTUS;

EID: 34748855673     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2006.00292.x     Document Type: Article

References (36)

1. Berry, M.D 2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90, 257 271.
2. Borowsky, B., Adham, N., Jones, K.A., Raddatz, R., Artymyshyn, R., Ogozalek, K.L., Durkin, M.M., Lakhlani, P.P., Bonini, J.A., Pathirana, S., Boyle, N., Pu, X., Kouranova, E., Lichtblau, H., Ochoa, F.Y., Branchek, T.A. Gerald, C 2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98, 8966 8971.
3. Braff, D.L., Geyer, M.A. Swerdlow, N.R 2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156, 234 258.
4. Branchek, T.A. Blackburn, T.P 2003) Trace amines receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3, 90 97.
5. Breier, A., Su, T-P., Saunders, R., Carson, R.E., Kolachana, B.S., de Bartolomeis, A., Weinberger, D.R., Weisenfeld, N., Malhotra, A.K., Eckelman, W.C. Pickar, D 1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94, 2569 2574.
6. Bunzow, J.R., Sonders, M.S., Arttamangkul, S., Harrison, L.M., Zhang, G., Quigley, D.I., Darland, T., Suchland, K.L., Pasumamula, S., Kennedy, J.L., Olson, S.B., Magenis, R.E., Amara, S.G. Grandy, D.K 2001) Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60, 1181 1188.
7. Corripio, I., Perez, V., Catafau, A.M., Mena, E., Carrio, I. Alvarez, E 2006) Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis. Neuroimage 29, 662 666.
8. Frances, H., Lienard, C. Monier, C 1990) Isolation-induced social behavioural deficit in mice and its relation to stimulant drugs. Pharmacol Res 22, 171 177.
9. Gainetdinov, R.R., Wetsel, W.C., Jones, S.R., Levin, E.D., Jaber, M. Caron, M.G 1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397 401.
10. 3H] beta-phenylethylamine binding sites in rat brain. Eur J Pharmacol 83, 147 148.
11. Hirvonen, J., van Erp, T.G., Huttunen, J., Aalto, S., Nagren, K., Huttunen, M., Lonnqvist, J., Kaprio, J., Hietala, J. Cannon, T.D 2005) Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry 62, 371 378.
12. 3H] tryptamine: high affinity binding sites in rat brain. Eur J Pharmacol 78, 475 478.
13. Kellendonk, C., Simpson, E., Polan, H., Malleret, G., Vronskaya, S., Winiger, V., Moore, H. Kandel, E 2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49, 603 615.
14. Laruelle, M., Abi-Dargham, A., Gil Rkegeles, L. Innis, R 1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46, 56 72.
15. Lindemann, L., Ebeling, M., Kratochwil, N.A., Bunzow, J.R., Grandy, D.K. Hoener, M.C 2005) Trace amine associated receptors form structurally and functionally distinct subfamilies of novel G-protein coupled receptors. Genomics 85, 372 385.
16. Miller, G.M., Verrico, C.D., Jassen, A., Konar, M., Yang, H., Panas, H., Bahn, M., Johnson, R. Madras, B.K 2005) Primate trace amine receptor 1 modulation by dopamine transporter. J Pharmacol Exp Ther 313, 983 994.
17. Nguyen, T.V. Juorio, A.V 1989) Binding sites for brain trace amines. Cell Mol Neurobiol 9, 297 311.
18. Olivier, B., Leahy, C., Mullen, T., Paylor, R., Groppi, V.E., Sarnyai, Z. Brunner, D 2001) The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics? Psychopharmacology 156, 284 290.
19. Parker, E.M. Cubeddu, L.X 1988) Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245, 199 210.
20. Paxinos, G. Franklin, K.J.B 2001) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
21. Powell, C.M. Miyakawa, T 2006) Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry 59, 1198 1207.
22. Powell, S.B., Lehmann-Masten, V.D., Paulus, M.P., Gainetdinov, R.R., Caron, M.G. Geyer, M.A 2004) MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology 173, 310 317.
23. Roeder, T 2005) Tyramine and octopamine: ruling behavior and metabolism. Annu Rev Entomol 50, 447 477.
24. 1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology 170, 173 179.
25. Scanlan, T.S., Suchland, K.L., Hart, M.E., Chiellini, G., Huang, Y., Kruzich, P.J., Frascarelli, S., Crossley D.A., II., Bunzow, J.R., Ronca-Testoni, S., Lin, E.T., Hatton, D., Zucchi, R. Grandy, D.K 2004) 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10, 638 642.
26. Seeman, P., Chau-Wong, M., Tedesco, J. Wong, K 1975) Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci USA 72, 4376 4380.
27. 3H]spiperone depend on tissue concentration: analysis and examples. J Neurochem 43, 221 235.
28. Seeman, P., Watanabe, M., Grigoriadis, D., Tedesco, J.L., George, S.R., Svensson, U., Nilsson, J.L.G. Neurneyer, J.L 1985) Dopamine D2 receptor binding sites for agonists. A tetrahedral model. Mol Pharmacol 28, 391 399.
29. Seeman, P., Tallerico, T. Ko, F 2003) Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: implications for human positron emission tomography. Synapse 49, 209 215.
30. Seeman, P., Weinshenker, D., Quirion, R., Srivastava, L., Bhardwaj, S.K., Grandy, D.K., Premont, R., Sotnikova, T., Boksa, P., El-Ghundi, M., O'Dowd, B.F., George, S.R., Perreault, M.L., Mannisto, P.T., Robinson, S., Palmiter, R.D. Tallerico, T 2005) Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci USA 102, 3513 3518.
31. Sotnikova, T.D., Budygin, E.A., Jones, S.R., Dykstra, L.A., Caron, M.G. Gainetdinov, R.R 2004) Dopamine transporter-dependent and -independent actions of trace amine β-phenylethylamine. J Neurochem 91, 362 373.
32. Sulzer, D., Sonders, M.S., Poulsen, N.W. Galli, A 2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75, 406 433.
33. Swerdlow, N.R., Keith, V.A., Braff, D.L. Geyer, M.A 1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256, 530 536.
34. Van der Heyden, J.A., Zethof, T.J. Olivier, B 1997) Stress-induced hyperthermia in singly housed mice. Physiol Behav 64, 463 470.
35. Võikar, V., Polus, A., Vasar, E. Rauvala, H 2005) Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences. Genes Brain Behav 4, 240 252.
36. Xie, Z., Madras, B.K. Miller, G.M 2005). Brain distribution of rhesus monkey trace amine receptors TA1 and TA4. Program No. 451.14 Abstract Viewer/Itinerary Planner, Society for Neuroscience, Washington, DC, Online.